MeSH Browser

MeSH Heading: Zanamivir
Tree Number(s): D02.078.370.926; D02.241.081.844.562.668.775; D02.241.511.902.562.668.775; D03.383.663.859; D09.067.687.668.775; D09.811.589.668.775
Unique ID: D053243
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D053243
Scope Note: A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE.
Entry Term(s): 2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid; 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid; 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid; 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid; 4-Guanidino-Neu5Ac2en; 5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid; GG 167; GG-167; GG167; Relenza
Pharm Action: Antiviral Agents
Enzyme Inhibitors
Registry Number: L6O3XI777I
Related Numbers: 139110-80-8
CAS Type 1 Name: 5-acetylamino-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid
Public MeSH Note: 2007; ZANAMIVIR was indexed under SIALIC ACIDS (1998-2006)
History Note: 2007
Date Established: 2007/01/01
Date of Entry: 2006/07/05
Revision Date: 2017/05/24

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

economics (EC)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Zanamivir MeSH Descriptor Data 2024